Comparison of the longevity of implantable cardioverter-defibrillator devices by different manufacturers

Int J Cardiol. 2014 Aug 1;175(2):380-2. doi: 10.1016/j.ijcard.2014.05.042. Epub 2014 May 17.

Authors

Konstantinos C Siontis¹, Ioannis Pantos², Demosthenes G Katritsis³

Affiliations

¹ Department of Medicine, Mayo Clinic, Rochester, MN, USA.
² Department of Cardiology, Athens Euroclinic, Athens, Greece; Medical and Radiation Physics, Department of Radiology, University of Athens, Greece.
³ Department of Cardiology, Athens Euroclinic, Athens, Greece. Electronic address: dkatritsis@euroclinic.gr.

PMID: 24874912
DOI: 10.1016/j.ijcard.2014.05.042

No abstract available

Keywords: Cardiac resynchronization therapy; Device longevity; Implantable cardioverter-defibrillator.

Publication types

Comparative Study
Letter
Review

MeSH terms

Animals
Cardiac Resynchronization Therapy / trends*
Defibrillators, Implantable / standards
Defibrillators, Implantable / trends*
Humans
Manufacturing Industry / standards
Manufacturing Industry / trends*